HEXO Corp

HEXO Corp. engages in the provision of cannabis and cannabis products. The company was founded by Sébastien St. Louis and Adam Miron on October 29, 2013 and is headquartered in Gatineau, Canada.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Hydropothecary is a licensed producer of medical marijuana under Health Canada’s Access to Cannabis for Medical Purposes Regulations.Their leadership team brings proven scientific, financial, regulatory and entrepreneurial expertise to the rapidly evolving Canadian medical marijuana industry.Hydropothecary is an award-winning medical cannabis producer located on a 143-acre farm in Gatineau, Quebec, in the National Capital Region. Their focus is on product innovation, advanced natural growing techniques, client health and safety, and exceptional customer service. They take their commitment to customers seriously, offering exceptional packaging, courier delivery in Canada (Saturdays where available) and their bilingual, 24-hour customer service.

Cronos Group

CannTrust Holdings

These popular pot stocks should remain off-limits this month.

3 Marijuana Stocks to Avoid Like the Plague in November

Houston, Canadian marijuana stocks have a problem.

It's Official: Canadian Pot Growers Are Cutting Output

HEXO's (HEXO) CEO Sebastien St-Louis on Q4 2019 Results - Earnings Call Transcript

Another Cannabis Stock Is Disappointing Investors

Hexo Corp. (TSX: HEXO) (NYSE: HEXO) posted a fourth-quarter adjusted net loss of CA$43.73 million ($33.5 million) Tuesday, sending the cannabis company's stock lower.

Hexo Stock Falls After Cannabis Company Posts Q4 Loss

The licenses will allow the company to sell "Cannabis 2.0" products from its home in Quebec and conduct R&D activities in an Ontario facility.

HEXO Wins a New Pair of Licenses

Canopy Growth

If you own any of these marijuana stocks, you'd better have a strong stomach.

The 3 Most Volatile Cannabis Stocks

Canadian cannabis company Hexo Corp.'s U.S.-listed shares HEXO, -2.52% HEXO, -2.57% fell 6.5% in premarket trade Tuesday, after the company's fiscal fourth-quarter loss widened from the year earlier.

Hexo shares slide 6.5% premarket after Canadian cannabis company's loss widens

Net Revenue of $15.4M, Up from $13.0M in Prior Quarter

HEXO Corp reports financial results for the fourth quarter and 2019 fiscal year

GATINEAU, Quebec, Oct.  28, 2019  (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX:HEXO; NYSE:HEXO) is pleased to announce it has received licences from Health Canada for its cannabis Centre of Excellence in Belleville, Ontario, for research, and for the sale of cannabis topicals, extracts, edibles and beverages from its flagship Gatineau campus. 

HEXO Corp granted new licences: Belleville Centre of Excellence, research, sale of new cannabis categories

One of the fastest growing industries on the planet is now handing out pink slips.

Is This Another Sign That Pot Stocks Are in Trouble?

CIBC downgraded Hexo Corp. stock HEXO, -6.32% HEXO, -5.70% to underperformer from neutral on Friday after the company announced that it had cut 200 jobs as the Canadian legal cannabis market is evolving more slowly than expected.

Hexo stock downgraded by CIBC after job cuts highlight series of challenges

Around 200 employees, including executives, are losing their jobs.

HEXO Hands Out Pink Slips, Delays Earnings Release

2019 has been rough on cannabis-based investments, and Hexo stock has taken the brunt of the volatility. Still, despite the extreme ugliness, there are multiple longer-term bullish factors to consider.

5 Reasons Why I Still Believe in Hexo Stock

Lower projected revenue is forcing it to restructure its workforce.

Marijuana Company HEXO Slashes 200 Jobs

Canadian cannabis company Hexo Corp. HEXO, -6.02% HEXO, -3.85% said Thursday it has cut 200 jobs as it works to adapt to a changing -- and smaller-than-expected -- Canadian cannabis market.

Canadian cannabis company Hexo cuts 200 jobs as Canadian market lags expectations

GATINEAU, Quebec, Oct.  24, 2019  (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX:HEXO; NYSE:HEXO) announced today it has taken steps to reduce its workforce. The Company is rightsizing its operations to adjust to a changing market and regulatory environment with a view towards profitability and long-term stability.

HEXO Corp aligns its operations with its 2020 expectations, reduces cost structure

HEXO Corp (TSX:HEXO) (NYSE:HEXO) said Wednesday it is conducting a $70-million private placement of convertible debentures.

Hexo Announces $70M Private Placement, Postpones Q4 Report

Aurora Cannabis

Innovative Industrial Properties

Neptune Wellness Solutions Inc.

Despite high hopes, pessimism keeps building with these pot stocks. However, not all of it may be warranted.

Short Sellers Continue to Pile Into These 4 Marijuana Stocks

Hexo Corp. HEXO, +4.84% on Wednesday postponed the release of its fourth-quarter earnings to Oct.

Hexo postpones Q4 earnings release, plans $54 million debt raise

GATINEAU, Quebec, Oct.  23, 2019  (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX:HEXO; NYSE:HEXO) today announced that it has entered into subscription agreements with a group of investors pursuant to which the investors have agreed to purchase, on a private placement basis, $70 million principal amount of 8.0% unsecured convertible debentures of the Company (the “Debentures”). The Company has also announced that in light of the financing and additional time required to finalize its year end filings, the Company has rescheduled the release of its fourth quarter and full year ended July 31, 2019 financial results to October 28, 2019 and its earnings call to discuss these results to 8:30 a.m. EDT on Tuesday, October 29, 2019 (details below). All amounts are expressed in Canadian dollars.

HEXO Corp announces $70 million private placement of convertible debentures led by Directors, CEO, and long-term shareholders; reschedules FY 2019 earnings call

One major cannabis producer aims to take on the black market with a new line of value-priced pot.

It's on Like Donkey Kong: The Marijuana Price Wars Have Begun in Canada

Say hello to the company's new lower-priced line, Original Stash.

HEXO Moves to Grab Budget Cannabis Customers

Plans to launch cannabis-infused beverages lit a fire beneath the beaten-down marijuana stock.

Why HEXO Stock Soared Today

Marijuana stocks mostly rebounded Thursday, a day that marks the start of the next phase of recreational cannabis sales in Canada.
The post Marijuana Stocks Enter Legalization 2.0, Unveil These New Products appeared first on Investor's Business Daily.

News for HEXO Corp Stock (HEXO)